Varex Imaging Past Earnings Performance
Past criteria checks 0/6
Varex Imaging has been growing earnings at an average annual rate of 31.5%, while the Medical Equipment industry saw earnings growing at 12.4% annually. Revenues have been growing at an average rate of 3% per year.
Key information
31.5%
Earnings growth rate
31.5%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 3.0% |
| Return on equity | -8.6% |
| Net Margin | -5.9% |
| Last Earnings Update | 27 Sep 2024 |
Recent past performance updates
Recent updates
Varex Imaging Corporation: A Mixed Picture
Jan 21Varex Imaging (NASDAQ:VREX) Is Finding It Tricky To Allocate Its Capital
Dec 19
There's Reason For Concern Over Varex Imaging Corporation's (NASDAQ:VREX) Massive 29% Price Jump
Nov 07Does Varex Imaging (NASDAQ:VREX) Have A Healthy Balance Sheet?
Oct 22Varex Imaging: Headroom Capped Without Higher Earnings On Capital Employed
Sep 11Little Excitement Around Varex Imaging Corporation's (NASDAQ:VREX) Earnings
Aug 20We Like Varex Imaging's (NASDAQ:VREX) Earnings For More Than Just Statutory Profit
May 10Varex Imaging Corporation: The Picture Is Cloudy After Quarterly Results
Feb 07We Like These Underlying Return On Capital Trends At Varex Imaging (NASDAQ:VREX)
Dec 14Is Varex Imaging (NASDAQ:VREX) A Risky Investment?
Nov 05Is There Now An Opportunity In Varex Imaging Corporation (NASDAQ:VREX)?
Oct 29Varex Imaging (NASDAQ:VREX) Hasn't Managed To Accelerate Its Returns
Sep 27What Is Varex Imaging Corporation's (NASDAQ:VREX) Share Price Doing?
Jul 21These 4 Measures Indicate That Varex Imaging (NASDAQ:VREX) Is Using Debt Reasonably Well
Jun 15Is It Too Late To Consider Buying Varex Imaging Corporation (NASDAQ:VREX)?
Mar 25Varex Imaging Corporation's (NASDAQ:VREX) CEO Might Not Expect Shareholders To Be So Generous This Year
Feb 04Is Varex Imaging (NASDAQ:VREX) A Risky Investment?
Jan 31Returns On Capital At Varex Imaging (NASDAQ:VREX) Paint A Concerning Picture
Dec 22Revenue & Expenses Breakdown
How Varex Imaging makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 27 Sep 24 | 811 | -48 | 138 | 87 |
| 28 Jun 24 | 833 | 34 | 135 | 87 |
| 29 Mar 24 | 856 | 42 | 132 | 85 |
| 29 Dec 23 | 878 | 45 | 131 | 85 |
| 29 Sep 23 | 893 | 48 | 128 | 85 |
| 30 Jun 23 | 897 | 29 | 128 | 83 |
| 31 Mar 23 | 880 | 29 | 126 | 83 |
| 30 Dec 22 | 866 | 32 | 116 | 79 |
| 30 Sep 22 | 859 | 30 | 117 | 77 |
| 01 Jul 22 | 854 | 26 | 116 | 75 |
| 01 Apr 22 | 851 | 30 | 115 | 74 |
| 31 Dec 21 | 840 | 25 | 122 | 73 |
| 01 Oct 21 | 818 | 17 | 125 | 72 |
| 02 Jul 21 | 762 | -18 | 127 | 71 |
| 02 Apr 21 | 722 | -58 | 129 | 71 |
| 01 Jan 21 | 715 | -63 | 133 | 74 |
| 02 Oct 20 | 738 | -58 | 133 | 79 |
| 03 Jul 20 | 771 | -23 | 131 | 81 |
| 03 Apr 20 | 796 | 4 | 131 | 83 |
| 03 Jan 20 | 795 | 11 | 126 | 81 |
| 27 Sep 19 | 781 | 16 | 122 | 78 |
| 28 Jun 19 | 783 | 7 | 116 | 79 |
| 29 Mar 19 | 778 | 13 | 117 | 79 |
| 28 Dec 18 | 783 | 19 | 119 | 82 |
| 28 Sep 18 | 773 | 28 | 123 | 83 |
| 29 Jun 18 | 784 | 42 | 116 | 84 |
| 30 Mar 18 | 763 | 49 | 110 | 81 |
| 29 Dec 17 | 717 | 52 | 99 | 74 |
| 29 Sep 17 | 698 | 52 | 103 | 67 |
| 30 Jun 17 | 655 | 59 | 96 | 59 |
| 31 Mar 17 | 636 | 66 | 90 | 56 |
| 30 Dec 16 | 631 | 66 | 91 | 54 |
| 30 Sep 16 | 620 | 69 | 86 | 54 |
| 01 Jul 16 | 608 | 62 | 80 | 55 |
| 02 Oct 15 | 632 | 80 | 73 | 50 |
| 26 Sep 14 | 685 | 110 | 63 | 40 |
Quality Earnings: VREX is currently unprofitable.
Growing Profit Margin: VREX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VREX is unprofitable, but has reduced losses over the past 5 years at a rate of 31.5% per year.
Accelerating Growth: Unable to compare VREX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VREX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (19%).
Return on Equity
High ROE: VREX has a negative Return on Equity (-8.59%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 23:42 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/27 |
| Annual Earnings | 2024/09/27 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Varex Imaging Corporation is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kyle Bauser | B. Riley Securities, Inc. |
| Lawrence Solow | CJS Securities, Inc. |
| Rajbir Denhoy | Jefferies LLC |